4//SEC Filing
Bench David 4
Accession 0001213900-22-019913
CIK 0000316253other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:58 PM ET
Size
12.8 KB
Accession
0001213900-22-019913
Insider Transaction Report
Form 4
Bench David
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock, $0.01 Par Value
2022-04-13$2.90/sh+880$2,552→ 880 total(indirect: By Trust) - Award
Common Stock, $0.01 Par Value
2022-04-14$2.90/sh+1,620$4,698→ 2,500 total(indirect: By Trust)
Holdings
- 87,500
Stock Option (to acquire Common Stock)
Exercise: $3.36From: 2023-02-11Exp: 2027-02-11→ Common Stock (87,500 underlying) - 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (55,400 underlying) - 87,500
Stock Option (to acquire Common Stock)
Exercise: $2.98From: 2023-03-24Exp: 2027-03-24→ Common Stock (87,500 underlying) - 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying) - 4,138(indirect: By 401(k))
Common Stock, $0.01 Par Value
Footnotes (3)
- [F1]Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
- [F2]Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
- [F3]The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001797876
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:58 PM ET
- Size
- 12.8 KB